DENVER - TelAve -- Sploot Veterinary Care, a leading provider of modern and advanced veterinary care, today announced an exclusive regional U.S. partnership with DeepScan Diagnostics, the innovator behind the world's most advanced and comprehensive cell-free DNA (cfDNA) screening tests for pets. This collaboration brings DeepScan's non-invasive, early detection test—already successfully utilized in Europe—to the U.S. market for the first time, and only through Sploot.

DeepScan's CFD (cell-free DNA) test identifies hidden signs of disease before symptoms appear—empowering pet parents with early, actionable insights. By detecting conditions like cancer, chronic inflammation, and organ damage earlier than traditional blood work, this technology enables earlier intervention, more treatment options, and better outcomes. Through this trailblazing approach, Sploot continues to redefine veterinary care by making advanced diagnostics more accessible and effective for pet parents.

More on TelAve News

• Success for Global Communications Leader IQSTEL, Inc. Growing From $13 Million Revenue in 2018 to Nearly $300 Million Last Year
• Artbound: "The Cheech" Awarded Two 2025 LA Area EMMY Awards — Honored in ARTS & MUSIC COMPOSITION
• Rising Conservative Star Jordan Brace Emerges as Influential Political Voice with Elite Washington Connections
• Conservative Latinos for PA Shaping the Future of Hispanic Community, Guest State Treasurer Stacy Garrity
• Chasing Creative Plants Roots in Palm Coast, Builds Marketing Systems for Modern B2B Brands

"We are excited to bring this breakthrough screening technology to pet parents in Colorado and Illinois" said Yoav Mordowicz, Co-Founder and Co-CEO at Sploot. "This partnership is a natural extension for our commitment to proactive, science-backed care - and it helps us continue redefining what's possible in everyday veterinary wellness, while enhancing the quality and longevity of pets' lives."

With this partnership, Sploot further reinforces its role as a pioneer in adopting next-generation diagnostics and applying precision medicine to everyday pet care.

"Partnering with Sploot was a natural choice for us," said Franz Mittler, Chief Commercial Officer at DeepScan. "Their forward-thinking approach to veterinary care, combined with our innovative screening test, will empower pet parents with vital information that was previously unavailable in the U.S. market."

About Sploot Veterinary Care

Sploot Veterinary Care is redefining the veterinary experience with a modern, pet-parent-first approach. Operating clinics in Denver, Chicago and Colorado Springs, Sploot offers comprehensive services - including primary, urgent, emergency and specialty care – under one roof. As a FearFree practice, Sploot prioritizes reducing pet stress and anxiety during every visit, ensuring a calm and compassionate environment. Their state-of-the-art facilities are open 8am-8pm, 365 days a year, providing same-day appointments and a seamless digital experience. With a focus on transparency, convenience and exceptional care, Sploot is committed to making veterinary services more accessible and stress-free for both pets and their parents.

More on TelAve News

• David M. White, DDS Celebrates 500 Five-Star Reviews in Reno
• BJ Simmons Releases Trapped In
• Advantai Group & One NZ launch groundbreaking Mobile solution to supercharge brand loyalty in NZ
• Shincheonji Reaches World-Class Level At International Taekwondo Competition
• TNT Removal & Disposal Celebrates Record Year Helping Pennsylvania Property Owners Reclaim Space

About DeepScan Diagnostics:

DeepScan Diagnostics is redefining pet healthcare by making early detection accessible, affordable, and transformative. Utilizing advanced, non-invasive cell-free DNA measurements, DeepScan empowers veterinarians and pet parents with precise health screenings, often identifying issues before symptoms appear. With a commitment to extending and enhancing pets' lives through proactive and personalized care, DeepScan is pioneering precision diagnostics and building the largest cfDNA dataset to improve decision-making, treatment options, and peace of mind for both pet parents and veterinary professionals.